Evaluating Risks, Costs, and Benefits of New and Emerging...

Journal of managed care pharmacy 2012 / 12 Vol. 18; Iss. 9 Supp B

Evaluating Risks, Costs, and Benefits of New and Emerging Therapies to Optimize Outcomes in Multiple Sclerosis

Bandari, Daniel S., Sternaman, Debora, Chan, Theodore, Prostko, Chris R., Sapir, Tamar
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
18
Language:
english
Journal:
Journal of Managed Care Pharmacy
DOI:
10.18553/jmcp.2012.18.S9-B.1
Date:
December, 2012
File:
PDF, 801 KB
english, 2012
Conversion to is in progress
Conversion to is failed